Author

Sarah B. Namugenyi

Minnesota Department of Health

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genomics· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Aine Niamh O’TooleiD· 1 shared Alexander L. GreningeriD· 1 shared Alisha M. BlockiD· 1 shared Amelia Weixler· 1 shared Andrew RambautiD· 1 shared Anna D. TischleriD· 1 shared Anthony C FriesiD· 1 shared Arif Mohammad TanmoyiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Aine Niamh O’TooleORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintSep 26, 2026

Mycobacterium tuberculosis requires riboflavin biosynthesis for survival in the host

Alisha M. Block, Sarah B. Namugenyi, Anna D. Tischler

This study shows that Mycobacterium tuberculosis needs riboflavin biosynthesis for survival during all stages of infection, suggesting it as a drug target.

DOI 10.64898/2026.09.25.754416

mousebulk RNA-seq

𝕏 PostBluesky

GenomicsWellcome Open ResearchPeer-reviewedJun 25, 2025

ARTIC RSV amplicon sequencing reveals global RSV genotype dynamics.

Daniel M Maloney, Goncalo Fernandes, Seema Jasim…·Andrew Rambaut

This study introduces two novel amplicon sequencing schemes for RSV A and B, demonstrating their effectiveness in generating high-quality genomes globally and revealing minimal geographic clustering of RSV sequences.

12 citationstop 2%

whole-genome sequencingexperimental assay

𝕏 PostBluesky